Tina J Hieken MD
@TJH0828
Followers
2K
Following
8K
Media
555
Statuses
10K
Surgical Oncologist, Professor of Surgery, @MayoClinic - Opinions are mine #breastcancer #melanoma #immunotherapy #microbiome #data #science
Rochester, MN
Joined May 2011
A Great Day 2 of #ESSO44 in Gothenburg Sweden🇸🇪 A warm welcome from @ESSOnews ! @BexeLindskog
@jzager99
@moffittnews
@LauraLorenzonMD
@WimCeelen
@Surgeonjakob
@itrisabel
@SOS_Pk
@hjmajid
@martajimenez135
@OlofssonBagge
@AndreasBrandl8
@GabrielleVanRam
@TJH0828
@CashinPtr
0
9
16
Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Elinor Bexe Lindskog 🇸🇪 The Immune Microenvironment in Peritoneal Metastases The immune landscape of peritoneal metastases differs from other metastatic sites. Peritoneal lesions show a fibro-inflammatory,
1
13
21
We were honored to recognize Dr. Selwyn M. Vickers, MD, FACS, as the CoC Oncology Lecturer this year at Clinical Congress. CoC chair Dr. Laurie Kirstein, MD, FACS, presents Dr. Vickers his award at #ACSCC2025 after his fascinating lecture! @AmCollSurgeons @DrVickersMSK
0
3
16
Thank you to everyone who attended the SSO Women in Cancer Surgery Lunch Discussion, HerSurgStory: Illuminating Journeys, Uniting Excellence! We’re grateful to our amazing panelists for sharing their stories and insights, what an inspiring event! #SSOCommunity #ACSCC25
0
6
25
Come visit us at the ACS Cancer Programs booth during #ACSCC2025! Our team is here to answer your questions and share vital cancer care resources! #ACSCancerPrograms #CoC #NAPRC #AJCC #NAPRC #ACSCC25
0
2
4
Featured: #Postmastectomy #RadiationTherapy : An ASTRO/ASCO/SSO Clinical Practice Guideline @YAbdouMD @pnbarry
https://t.co/DPYn8cqauE
@DrEmilySiegel
@SyedAAhmad5
0
7
10
Is PET-CT a good predictor of the pathological response post neoadjuvant treatment in Stage III melanoma? We report on a cohort of real-world patients treated with immunotherapy alone or in combination with targeted therapy. @AnnSurgOncol @TJH0828
link.springer.com
Annals of Surgical Oncology - Clinical stage III melanoma has a high recurrence rate following surgical dissection. The use of neoadjuvant treatment has been shown to improve long-term outcomes...
1
2
4
🚨 Deadline Tomorrow! Don’t miss your chance to apply for the 2026 ACS/ASBrS International Scholarship. The $5000 award includes attendance at ASBrS 2026, our 27th Annual Meeting in Seattle. Apply Now: https://t.co/Nyvf6r6Nwp Deadline: August 26, 2025
1
2
7
The FDA’s decision not to approve RP1 - a novel treatment for advanced #melanoma - was disappointing to the entire melanoma community. Yet, our commitment is unwavering.
2
1
8
Advance your research by applying for an SSO Clinical Investigator or Young Investigator Award! SSO is accepting proposals for both awards. Learn more about the awards, criteria, deadlines, and how to apply: https://t.co/yXK0mBYOkM
0
2
5
Featured: The Landmark Series: Minimally Invasive #PancreaticResection for Ductal Adenocarcinoma, Updates, Trends, and Future Considerations. @DiazAdrian10 @HoggNDMD
https://t.co/a2W98rSgc7
@DrSabha
@SyedAAhmad5
0
8
17
Nice to see this @ASCO 2025 presentation published @MayoClinic @MayoCancerCare @MayoClinicSurg #melanoma #Immunotherapy
The @SU2C Catalyst®-@genentech Team led by Matthew Block and @TJH0828 just published the results of Arm C of the NeoACTIVATE trial in the European Journal of Cancer showing that among patients with high-risk resectable Stage III melanoma, neoadjuvant atezolizumab/tiragolumab is a
0
0
5
In this webinar members of the SSO Fellows and Young Attendings Committee will elaborate and provide clinical tips for fellowship, research, and personal life. Don't miss it: https://t.co/7C9q5MyBp9
0
3
8
#AudioVisualAbstract : Mainstream Germline #GeneticTesting with Expanded Eligibility for Early #BreastCancer Patients in a Large Integrated Health System https://t.co/xJuiJfrbwm
@belenmerck
@SyedAAhmad5
0
8
10
July Issue: National Variation in Implementation of #SentinelLymphNodeBiopsy for Clinically Node-Positive Patients Undergoing Neoadjuvant Therapy https://t.co/mAPxAY3aIa
@EdiBonci
@SyedAAhmad5
0
7
11
Cancer Programs Medical Director Dr. Ronald Weigel speaks at “Breaking Barriers: It Takes a Village to Shape the Future of Quality Patient Care” at #ACSQSC25.
0
3
9
In this episode of SurgOnc Today, Dr. Chandler S. Cortina, Dr. Ash B. Alpert and Dr. Elizabeth J. Cathcart-Rake discuss the clinical significance of providing gender-inclusive cancer care for sex-organ specific cancers. Listen now: https://t.co/R3hWDf0xpV
0
1
5
Melanoma prevention is at risk, join us and take action today! We are actively mobilizing to demand that Congress protect the $6 million in funding for the @CDCgov's Skin Cancer Prevention Program, a vital, life-saving initiative now facing elimination. The President’s FY26
0
2
2